gypenoside-LXXV and Cognitive-Dysfunction

gypenoside-LXXV has been researched along with Cognitive-Dysfunction* in 2 studies

Other Studies

2 other study(ies) available for gypenoside-LXXV and Cognitive-Dysfunction

ArticleYear
Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cognition; Cognitive Dysfunction; Diabetes Mellitus; Disease Models, Animal; Glucose; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt

2023
A novel natural PPARĪ³ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db mice.
    Phytotherapy research : PTR, 2022, Volume: 36, Issue:4

    Topics: Animals; Brain; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Gynostemma; Insulin; Insulin Resistance; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt; Saponins; Triterpenes

2022